Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison

Digestive and Liver Disease

Volumn 34, Issue 2, 2002, Pages 99-104

  Frazzoni, M ^a   Grisendi, A ^a   Lanzani, A ^a   Melotti, G ^a   De Micheli, E ^a  

^a Nuovo Ospedale S Agostino   (Italy)

Author keywords

Gastro oesophageal reflux; Lansoprazole; Laparoscopi fundoplication

Indexed keywords

LANSOPRAZOLE;

ADULT; AMBULATORY MONITORING; ANTIREFLUX OPERATION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MANOMETRY; MEDICAL DECISION MAKING; PATIENT CARE; PATIENT INFORMATION; PATIENT REFERRAL; STOMACH FUNDOPLICATION; SYMPTOM; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; ENZYME INHIBITORS; FEMALE; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; H(+)-K(+)-EXCHANGING ATPASE; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; LAPAROSCOPY; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0036186914     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80237-7     Document Type: Article

References (37)

1. Long-term management of gastroesophageal reflux disease and its complications
2. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
3. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
4. The changing epidemiology of esophageal cancer
5. Proton pump inhibitors for Barrett's oesophagus
6. Barrett's oesophagus and proton pump inhibitors: A pathological perspective
7. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans
8. Surgery for reflux disease. Reflections of a gastroenterologist
9. Nissen fundoplication for gastroesophageal reflux disease - Evaluation of primary repair in 100 consecutive patients
10. Long-term comparison of antireflux surgery versus conservative therapy for reflux esophagitis
11. Laparoscopic Nissen fundoplication - 200 consecutive cases
12. Guidelines for the diagnostic and therapeutic management of patients with gastro-oesophageal reflux disease. A position statement of The Italian Association of Hospital Gastroenterologists (AIGO). Italian Society of Endoscopy (SIED, and Italian Society of Gastroenterology (SIGE)
13. Laparoscopic surgery for gastroesophageal reflux disease
14. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
15. Heartburn - A serious symptom
16. Oesophageal pH monitoring: How gold is the gold standard?
17. Normal 24-hour ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender
18. Daytime reduction of gastro-oesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment
19. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: Testing while on therapy identifies the need for more aggressive anti-reflux therapy
20. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis
21. A comparison of five maintenance therapies for reflux esophagitis
22. Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study
23. Standards for oesophageal manometry. A position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente (GISMAD)
24. The preoperative evaluation of patients considered for laparoscopic antireflux surgery
25. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects
26. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in The Netherlands
27. Lifetime costs of surgical versus medical treatment of severe gastroesophageal reflux disease in Finland
28. Choice of long-term strategy for the management of patients with severe esophagitis: A cost-utility analysis
29. Long term management of gastro-oesophageal reflux disease with omeprazole or anti-reflux surgery: Results of a prospective, randomized clinical trial
30. Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety
31. Gastroesophageal reflux disease and its complications
32. A comparison of observational studies and randomized, controlled trials
33. Randomized, controlled trials, observational studies, and the hierarchy of research designs
34. Oesophageal intestinal metaplasia
35. Endoscopic regression of Barrett's esophagus during omeprazole treatment; a randomised double blind study
36. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
37. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease